desipramine has been researched along with Adenocarcinoma, Basal Cell in 3 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to examine the effect of individual reactivity to stress and 24-day desipramine (DES) administration on the metastatic colonization of adenocarcinoma MADB 106 cells in the lungs of Wistar rats." | 7.88 | Stimulatory effect of desipramine on lung metastases of adenocarcinoma MADB 106 in stress highly-sensitive and stress non-reactive rats. ( Basta-Kaim, A; Budziszewska, B; Curzytek, K; Glombik, K; Gruca, P; Grygier, B; Korzeniak, B; Kubera, M; Lason, W; Leskiewicz, M; Maes, M; Papp, M; Regulska, M; Rogoz, Z; Roman, A; Slusarczyk, J; Wrona, D, 2018) |
| " The aim of the present study was to examine the effect of individual reactivity to stress and 24-day desipramine (DES) administration on the metastatic colonization of adenocarcinoma MADB 106 cells in the lungs of Wistar rats." | 3.88 | Stimulatory effect of desipramine on lung metastases of adenocarcinoma MADB 106 in stress highly-sensitive and stress non-reactive rats. ( Basta-Kaim, A; Budziszewska, B; Curzytek, K; Glombik, K; Gruca, P; Grygier, B; Korzeniak, B; Kubera, M; Lason, W; Leskiewicz, M; Maes, M; Papp, M; Regulska, M; Rogoz, Z; Roman, A; Slusarczyk, J; Wrona, D, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grygier, B | 1 |
| Kubera, M | 1 |
| Wrona, D | 1 |
| Roman, A | 1 |
| Basta-Kaim, A | 1 |
| Gruca, P | 1 |
| Papp, M | 1 |
| Rogoz, Z | 1 |
| Leskiewicz, M | 1 |
| Budziszewska, B | 1 |
| Regulska, M | 1 |
| Korzeniak, B | 1 |
| Curzytek, K | 1 |
| Glombik, K | 1 |
| Slusarczyk, J | 1 |
| Maes, M | 1 |
| Lason, W | 1 |
| Szpunar, MJ | 1 |
| Burke, KA | 1 |
| Dawes, RP | 1 |
| Brown, EB | 1 |
| Madden, KS | 1 |
| Arimochi, H | 1 |
| Morita, K | 1 |
3 other studies available for desipramine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Stimulatory effect of desipramine on lung metastases of adenocarcinoma MADB 106 in stress highly-sensitive and stress non-reactive rats.
Topics: Adenocarcinoma; Animals; Antidepressive Agents; Cell Line, Tumor; Desipramine; Lung Neoplasms; Lymph | 2018 |
The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.
Topics: Adenocarcinoma; Adrenergic alpha-2 Receptor Agonists; Animals; Antidepressive Agents, Tricyclic; Apo | 2013 |
Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Cell Death; Cell Line, Tumor; Colonic Neoplasms; Desipramine; Dose-Respon | 2008 |